ReGen Biologics RGBOQ Stock
ReGen Biologics Price Chart
ReGen Biologics RGBOQ Financial and Trading Overview
ReGen Biologics stock price | 0.0000 USD |
Previous Close | 1.0E-6 USD |
Open | 1.0E-6 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 1.0E-6 - 1.0E-6 USD |
52 Week Range | 1.0E-6 - 0.0008 USD |
Volume | 4.82K USD |
Avg. Volume | 0 USD |
Market Cap | 97 USD |
Beta (5Y Monthly) | 0.499295 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | March 29, 1996 |
1y Target Est | N/A |
RGBOQ Valuation Measures
Enterprise Value | 7.85M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.4623586E-5 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 5.23 |
Enterprise Value/EBITDA | -0.616 |
Trading Information
ReGen Biologics Stock Price History
Beta (5Y Monthly) | 0.499295 |
52-Week Change | 0% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.0008 USD |
52 Week Low | 1.0E-6 USD |
50-Day Moving Average | 0.0008 USD |
200-Day Moving Average | 0.0008 USD |
RGBOQ Share Statistics
Avg. Volume (3 month) | 0 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 9.78M |
Float | N/A |
Short Ratio | 0 |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | 0 |
Short % of Float | N/A |
Short % of Shares Outstanding | 0% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2008 |
Most Recent Quarter (mrq) | June 30, 2009 |
Next Fiscal Year End | December 31, 2009 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -855.69% |
Gross Margin | 51.56% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -232.47% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 1.5M USD |
Revenue Per Share (ttm) | 0.22 USD |
Quarterly Revenue Growth (yoy) | 73.29% |
Gross Profit (ttm) | 681K USD |
EBITDA | -12747000 USD |
Net Income Avi to Common (ttm) | -17680000 USD |
Diluted EPS (ttm) | -0.15 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 2.47M USD |
Total Cash Per Share (mrq) | 0.25 USD |
Total Debt (mrq) | 8.83M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.403 |
Book Value Per Share (mrq) | -0.768 |
Cash Flow Statement
Operating Cash Flow (ttm) | -9680000 USD |
Levered Free Cash Flow (ttm) | -5015500 USD |
Profile of ReGen Biologics
Country | United States |
State | NJ |
City | Hackensack |
Address | 411 Hackensack Avenue |
ZIP | 07601 |
Phone | 201-651-5140 |
Website | N/A |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 15 |
ReGen Biologics Inc. designs, develops, manufactures, and markets medical devices for the repair and generation of soft tissue in humans, primarily for orthopedic applications. The company's proprietary collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular, and drug delivery. Its products include Menaflex collagen meniscus implant device, for use in surgical procedures for the reinforcement and repair of soft tissue injuries of the medial meniscus; and SharpShooter Tissue Repair System, an instrument that allows surgeons to place needles in hard-to-reach locations of the meniscus. The company sells its products in the United States, the European Union, the Republic of South Africa, Canada, Australia, Chile, and Japan. ReGen Biologics Inc. was formerly known as Aros Corp and changed its name to ReGen Biologics Inc. in November, 2002. ReGen Biologics Inc. was founded in 1987 and is headquartered in Hackensack, New Jersey. On April 8, 2011, ReGen Biologics Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on October 14, 2011.
Q&A For ReGen Biologics Stock
What is a current RGBOQ stock price?
ReGen Biologics RGBOQ stock price today per share is 0.0000 USD.
How to purchase ReGen Biologics stock?
You can buy RGBOQ shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ReGen Biologics?
The stock symbol or ticker of ReGen Biologics is RGBOQ.
Which industry does the ReGen Biologics company belong to?
The ReGen Biologics industry is Medical Instruments & Supplies.
How many shares does ReGen Biologics have in circulation?
The max supply of ReGen Biologics shares is 0.
What is ReGen Biologics Price to Earnings Ratio (PE Ratio)?
ReGen Biologics PE Ratio is 0.00000000 now.
What was ReGen Biologics earnings per share over the trailing 12 months (TTM)?
ReGen Biologics EPS is 0 USD over the trailing 12 months.
Which sector does the ReGen Biologics company belong to?
The ReGen Biologics sector is Healthcare.